SS
State Street Corp cut its VIR stake below 5%
State Street Corp reported owning 4.6% of Vir Biotechnology, Inc. (VIR) (7,822,781 shares) in a Schedule 13G filed Nov 10, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 10, 2026
- Source
- Schedule 13G